HILLSBOROUGH, NJ / ACCESSWIRE / May 28, 2017 / Bionical, a partner to the pharmaceutical and biotech industries, is pleased to announce that Andy Woolf, CEO, US has been named to PM360's 2017 Elite ...
WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...
LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionical Emas ("Bionical") or ("the Company"), the Early Access Programs and Clinical Trial Supply business, is selling its Clinical Development division, ...
Bionical, the integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, announces the strategic acquisition of Emas Pharma (Emas), a global Clinical Research ...
Bionical Health Group’s turnover topped £21m in its first full year, but restructuring costs and a £2m goodwill write-off hit ...
London, United Kingdom, September 29, 2019 --(PR.com)-- With less than 3 weeks left for the conference, SMi’s 9th Annual Orphan Drugs & Rare Diseases will be returning on October 15 and 16 in London.
NEW YORK & WILLINGTON, England & FLEMINGTON, N.J.--(BUSINESS WIRE)--Today, Sermo -- a social platform for peer-to-peer physician collaboration and frontline information sharing -- announced a ...
WILLINGTON, England, May 10, 2021 /PRNewswire/ -- Bionical Emas, a global specialist Clinical Research Organization (CRO), has today announced the launch of a U.S. Expanded Access Program for Jazz ...
Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...
SMi Reports: Interview excerpt with Bionical EMAS’ Executive VP, Tom Watson released for SMi’s 9th Annual Conference on Orphan Drugs & Rare Diseases, in London in less than 3 weeks With less than 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results